Gilead Sciences Unrealized Gains on Investments increased by 66.7% to $10.00M in Q3 2025 compared to the prior quarter. Over 3 years (FY 2020 to FY 2023), Unrealized Gains on Investments shows an upward trend with a 18.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Rising gains indicate strong performance of the underlying securities, whereas falling gains reflect market headwinds.
This metric tracks the total positive difference between the fair market value and the amortized cost of investment secu...
Commonly reported by all major banks; highly sensitive to interest rate fluctuations.
unrealized_gains_on_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.00M | $1.00M | $0.00 | $0.00 | $0.00 | $0.00 | $1.00M | $2.00M | $0.00 | $0.00 | $5.00M | $6.00M | $10.00M |
| QoQ Change | — | +0.0% | -100.0% | — | — | — | — | +100.0% | -100.0% | — | — | +20.0% | +66.7% |
| YoY Change | — | — | — | — | -100.0% | -100.0% | — | — | — | — | +400.0% | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.